United States Biotechnology & Medical Research

Abeona Therapeutics Inc (ABEO)

Track

Abeona Therapeutics Inc. experienced significant selling activity over the past ninety days, totaling approximately 4.35 million dollars. Key executives, including the CEO and CFO, offloaded shares following the most recent results financiers. Despite this divestment trend, the stock price appreciated by 17.7 percent during this period, reflecting varied market sentiment ahead of upcoming reports.
Ticker: ABEO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Abeona Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 21 Jul 2026
Value US$3,086,914.76 | Price 101.60 | Shares 61,665 (-39.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-21 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
61,665 -39.1%
101.60
US$3,086,915 		61,665 -39.1% 101.60 US$3,086,915
2026-07-09 2026-07-09 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
86,330 -10.9%
485.54
US$625,117 		86,330 -10.9% 485.54 US$625,117
2026-07-09 2026-07-09 S Sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
44,419 -22.3%
342.22
US$3,600,892 		44,419 -22.3% 342.22 US$3,600,892
2026-07-09 2026-07-09 S Sale
3.3
O'Malley Brendan M.

SVP, Chief Legal Officer

Officer
12,050 -2.7%
6.96
US$83,913 		12,050 -2.7% 6.96 US$83,913
2026-07-09 2026-07-09 S Sale
1.4
Vasanthavada Madhav

Chief Commercial Officer

Officer
12,606 -4.2%
6.96
US$87,784 		12,606 -4.2% 6.96 US$87,784
2026-07-09 2026-07-09 PrS Proposed sale
3.4
Seshadri Vishwas

Officer

Officer
67,971
6.96
US$473,330 		67,971 6.96 US$473,330
2026-07-09 2026-07-09 PrS Proposed sale
1.4
Vasanthavada Madhav

Officer

Officer
12,606
6.96
US$87,784 		12,606 6.96 US$87,784
2026-07-09 2026-07-09 PrS Proposed sale
3.6
Vazzano Joseph Walter

Officer

Officer
24,880
6.96
US$173,257 		24,880 6.96 US$173,257
2026-07-09 2026-07-09 PrS Proposed sale
3.3
O'Malley Brendan M.

Officer

Officer
12,050
6.96
US$83,913 		12,050 6.96 US$83,913
2026-07-06 2026-07-06 PrS Proposed sale
2.1
Silverstein Christine Berni

Former Director

Non-Executive Director
102,180
6.27
US$640,771 		102,180 6.27 US$640,771
2026-07-02 2026-06-30 S Sale
2.6
Alland Leila
Non-Executive Director
11,000 -6.3%
5.92
US$65,087 		11,000 -6.3% 5.92 US$65,087
2026-06-15 2026-06-15 S Sale
2.1
Silverstein Christine Berni
Non-Executive Director
18,160 -13.2%
5.71
US$103,695 		18,160 -13.2% 5.71 US$103,695
2026-06-15 2026-06-15 PrS Proposed sale
2.1
Silverstein Christine Berni

Director

Non-Executive Director
18,160
5.71
US$103,695 		18,160 5.71 US$103,695
2026-06-09 2026-06-09 PlS Planned sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
25,646 -4.7%
5.39
US$138,288 		25,646 -4.7% 5.39 US$138,288
2026-06-09 2026-06-09 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
13,421 -2.4%
5.30
US$71,188 		13,421 -2.4% 5.30 US$71,188
2026-06-09 2026-06-09 S Sale
3.3
O'Malley Brendan M.

SVP, Chief Legal Officer

Officer
6,305 -1.4%
5.30
US$33,443 		6,305 -1.4% 5.30 US$33,443
2026-06-09 2026-06-09 S Sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
31,916 -2.3%
5.30
US$169,289 		31,916 -2.3% 5.30 US$169,289
2026-06-09 2026-06-09 S Sale
1.4
Vasanthavada Madhav

Chief Commercial Officer

Officer
5,450 -1.8%
5.30
US$28,908 		5,450 -1.8% 5.30 US$28,908
2026-06-09 2026-06-09 PrS Proposed sale
3.6
Vazzano Joseph Walter

Officer

Officer
25,646
5.39
US$138,288 		25,646 5.39 US$138,288
2026-06-09 2026-06-08 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
10,271 -1.8%
5.43
US$55,766 		10,271 -1.8% 5.43 US$55,766
2026-06-09 2026-06-08 S Sale
3.3
O'Malley Brendan M.

SVP, Chief Legal Officer

Officer
4,826 -1.1%
5.43
US$26,203 		4,826 -1.1% 5.43 US$26,203
2026-06-09 2026-06-08 S Sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
24,428 -1.7%
5.43
US$132,632 		24,428 -1.7% 5.43 US$132,632
2026-06-09 2026-06-08 S Sale
1.4
Vasanthavada Madhav

Chief Commercial Officer

Officer
4,170 -1.3%
5.43
US$22,641 		4,170 -1.3% 5.43 US$22,641
2026-06-08 2026-06-08 PrS Proposed sale
3.4
Seshadri Vishwas

Officer

Officer
58,000
5.25
US$304,500 		58,000 5.25 US$304,500
2026-06-08 2026-06-08 PrS Proposed sale
3.3
O'Malley Brendan M.

Officer

Officer
12,000
5.25
US$63,000 		12,000 5.25 US$63,000
2026-06-08 2026-06-08 PrS Proposed sale
3.6
Vazzano Joseph Walter

Officer

Officer
25,000
5.25
US$131,250 		25,000 5.25 US$131,250
2026-06-08 2026-06-08 PrS Proposed sale
1.4
Vasanthavada Madhav

Officer

Officer
10,000
5.25
US$52,500 		10,000 5.25 US$52,500
2026-05-22 2026-05-22 S Sale
2.4
Alvino Mark
Non-Executive Director
6,500 -7.7%
5.46
US$35,463 		6,500 -7.7% 5.46 US$35,463
2026-05-22 2026-05-22 PrS Proposed sale
2.4
Alvino Mark

Director

Non-Executive Director
6,500
5.46
US$35,463 		6,500 5.46 US$35,463
2026-05-15 2026-05-15 PlS Planned sale
2.9
Crombez Eric
Non-Executive Director
26,143 -41.2%
5.53
US$144,636 		26,143 -41.2% 5.53 US$144,636
2026-05-15 2026-05-15 PrS Proposed sale
2.9
Crombez Eric

Director

Non-Executive Director
26,143
5.53
US$144,636 		26,143 5.53 US$144,636
2026-05-11 2026-05-11 S Sale
1.4
Vasanthavada Madhav

Chief Commercial Officer

Officer
5,548 -1.7%
5.96
US$33,073 		5,548 -1.7% 5.96 US$33,073
2026-05-11 2026-05-11 PrS Proposed sale
1.4
Vasanthavada Madhav

Officer

Officer
5,548
5.96
US$33,073 		5,548 5.96 US$33,073
2026-03-31 2026-03-31 PlS Planned sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
29,985 -2.1%
4.38
US$131,481 		29,985 -2.1% 4.38 US$131,481
2026-03-31 2026-03-31 PrS Proposed sale
3.4
Seshadri Vishwas

Officer

Officer
29,985
4.38
US$131,481 		29,985 4.38 US$131,481
2026-03-16 2026-03-16 PrS Proposed sale
3.6
Vazzano Joseph Walter

Officer

Officer
785
4.76
US$3,737 		785 4.76 US$3,737
2026-03-16 2026-03-16 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
785 -0.1%
4.76
US$3,737 		785 -0.1% 4.76 US$3,737
2026-02-09 2026-02-02 PrS Proposed sale
2.1
Silverstein Christine Berni

Director

Non-Executive Director
20,070
5.09
US$102,168 		20,070 5.09 US$102,168
2026-02-04 2026-02-02 S Sale
2.1
Silverstein Christine Berni
Non-Executive Director
20,070 -12.7%
5.09
US$102,168 		20,070 -12.7% 5.09 US$102,168
2026-02-02 2026-02-02 PrS Proposed sale
1.4
Wuchterl Donald A.

Director

Non-Executive Director
14,814
5.09
US$75,412 		14,814 5.09 US$75,412
2026-02-02 2026-02-02 PrS Proposed sale
2.9
Crombez Eric

Director

Non-Executive Director
16,284
5.09
US$82,886 		16,284 5.09 US$82,886
2026-02-02 2026-02-02 PrS Proposed sale
2.4
Alvino Mark

Director

Non-Executive Director
2,000
5.09
US$10,180 		2,000 5.09 US$10,180
2026-02-02 2026-02-02 PrS Proposed sale
2.6
Alland Leila

Director

Non-Executive Director
18,065
5.09
US$91,962 		18,065 5.09 US$91,962
2026-02-02 2026-02-02 S Sale
2.9
Crombez Eric
Non-Executive Director
16,284 -20.4%
5.09
US$82,895 		16,284 -20.4% 5.09 US$82,895
2026-02-02 2026-02-02 S Sale
1.4
Wuchterl Donald A.
Non-Executive Director
14,814 -8.1%
5.09
US$75,412 		14,814 -8.1% 5.09 US$75,412
2026-02-02 2026-02-02 S Sale
2.6
Alland Leila
Non-Executive Director
18,065 -9.4%
5.09
US$91,962 		18,065 -9.4% 5.09 US$91,962
2026-02-02 2026-02-02 S Sale
2.4
Alvino Mark
Non-Executive Director
2,000 -2.3%
5.09
US$10,181 		2,000 -2.3% 5.09 US$10,181
2026-01-26 2026-01-22 S Sale
1.4
Vasanthavada Madhav

Chief Commercial Officer

Officer
12,610 -3.8%
5.29
US$66,658 		12,610 -3.8% 5.29 US$66,658
2026-01-22 2026-01-22 PrS Proposed sale
1.4
Vasanthavada Madhav

Officer

Officer
12,610
5.29
US$66,658 		12,610 5.29 US$66,658
2026-01-22 2026-01-22 PrS Proposed sale
3.6
Vazzano Joseph Walter

Officer

Officer
18,666
5.33
US$99,507 		18,666 5.33 US$99,507
2026-01-22 2026-01-22 PrS Proposed sale
3.3
O'Malley Brendan M.

Officer

Officer
13,578
5.39
US$73,233 		13,578 5.39 US$73,233
2026-01-22 2026-01-22 PrS Proposed sale
3.4
Seshadri Vishwas

Officer

Officer
69,832
5.33
US$372,267 		69,832 5.33 US$372,267
2026-01-22 2026-01-22 S Sale
3.3
O'Malley Brendan M.

SVP, Chief Legal Officer

Officer
13,578 -2.9%
5.33
US$72,383 		13,578 -2.9% 5.33 US$72,383
2026-01-22 2026-01-22 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
18,666 -3.2%
5.33
US$99,507 		18,666 -3.2% 5.33 US$99,507
2026-01-22 2026-01-22 S Sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
69,832 -4.6%
5.33
US$372,267 		69,832 -4.6% 5.33 US$372,267
2026-01-21 2026-01-21 PrS Proposed sale
2.4
Alvino Mark

Director

Non-Executive Director
13,500
5.23
US$70,574 		13,500 5.23 US$70,574
2026-01-21 2026-01-21 S Sale
2.4
Alvino Mark
Non-Executive Director
13,500 -21.7%
5.23
US$70,574 		13,500 -21.7% 5.23 US$70,574
2025-12-29 2025-12-29 PrS Proposed sale
3.4
Seshadri Vishwas

Officer

Officer
25,000
5.31
US$132,695 		25,000 5.31 US$132,695
2025-12-29 2025-12-29 PlS Planned sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
25,000 -2.1%
5.31
US$132,740 		25,000 -2.1% 5.31 US$132,740
2025-11-14 2025-11-13 S Sale
2.4
Alvino Mark
Non-Executive Director
15,000 -19.4%
4.74
US$71,168 		15,000 -19.4% 4.74 US$71,168
2025-11-13 2025-11-13 PrS Proposed sale
2.4
Alvino Mark

Director

Non-Executive Director
15,000
4.74
US$71,168 		15,000 4.74 US$71,168
2025-10-16 2025-10-16 PrS Proposed sale
3.4
Seshadri Vishwas

Officer

Officer
249
5.49
US$1,366 		249 5.49 US$1,366
2025-10-16 2025-10-16 S Sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
249 -0.0%
5.49
US$1,366 		249 -0.0% 5.49 US$1,366
2025-10-01 2025-09-30 PlS Planned sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
25,000 -2.1%
5.24
US$130,930 		25,000 -2.1% 5.24 US$130,930
2025-10-01 2025-09-29 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
9,035 -2.0%
5.39
US$48,730 		9,035 -2.0% 5.39 US$48,730
2025-10-01 2025-09-29 S Sale
3.3
O'Malley Brendan M.

SVP, Chief Legal Officer

Officer
9,366 -2.6%
5.39
US$50,516 		9,366 -2.6% 5.39 US$50,516
2025-10-01 2025-09-29 S Sale
3.4
Seshadri Vishwas

Chief Executive Officer

Executive Director
19,274 -1.6%
5.39
US$103,954 		19,274 -1.6% 5.39 US$103,954
2025-09-29 2025-09-29 PrS Proposed sale
3.4
Seshadri Vishwas

Officer

Officer
44,274
5.39
US$238,792 		44,274 5.39 US$238,792
2025-09-29 2025-09-29 PrS Proposed sale
3.3
O'Malley Brendan M.

Officer

Officer
9,366
5.39
US$50,516 		9,366 5.39 US$50,516
2025-09-29 2025-09-29 PrS Proposed sale
3.6
Vazzano Joseph Walter

Officer

Officer
9,366
5.39
US$50,516 		9,366 5.39 US$50,516
2025-09-22 2025-09-22 PrS Proposed sale
3.3
O'Malley Brendan M.

Officer

Officer
17,376
5.86
US$101,749 		17,376 5.86 US$101,749
2025-09-22 2025-09-22 S Sale
3.3
O'Malley Brendan M.

SVP, Chief Legal Officer

Officer
688 -0.2%
5.43
US$3,736 		688 -0.2% 5.43 US$3,736
2025-08-15 2025-08-15 PrS Proposed sale
3.6
Vazzano Joseph Walter

Officer

Officer
15,000
7.36
US$110,358 		15,000 7.36 US$110,358
2025-08-15 2025-08-15 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
15,000 -3.1%
7.36
US$110,358 		15,000 -3.1% 7.36 US$110,358
2025-08-15 2025-08-14 S Sale
2.9
Crombez Eric
Non-Executive Director
4,718 -10.0%
6.93
US$32,683 		4,718 -10.0% 6.93 US$32,683
Explore more

More insider trading research around Abeona Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America